Regeneron Announces Presentation at the UBS Global Life Sciences ... ( TARRYTOWN N.Y. Sept. 13 /- Regeneron ...)

Regeneron Announces Presentation at the UBS Global Life Sciences Conference

Date:9/13/2010

TARRYTOWN, N.Y., Sept. 13 /PRNewswire-FirstCall/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) will webcast its presentation at the UBS Global Life Sciences Conference on Monday, September 20, 2010. The presentation is scheduled for 10:00 a.m. Eastern Time. The session may be accessed through the Company's web site, www.regeneron.com, on the Investor Relations page. An archived version of the presentation will be available after the live webcast through October 20, 2010.

Regeneron is a fully integrated biopharmaceutical company that discovers, develops, and commercializes medicines for the treatment of serious medical conditions. In addition to ARCALYST® (rilonacept) Injection for Subcutaneous Use, its first commercialized product, Regeneron has therapeutic candidates in Phase 3 clinical trials for the potential treatment of gout, diseases of the eye (wet age-related macular degeneration and central retinal vein occlusion), and certain cancers. Additional therapeutic candidates developed from proprietary Regeneron technologies for creating fully human monoclonal antibodies are in earlier stage development programs in rheumatoid arthritis and other inflammatory conditions, pain, cholesterol reduction, allergic and immune conditions and cancer. Additional information about Regeneron and recent news releases are available on Regeneron's web site at www.regeneron.com. Contact Information:Michael Aberman, M.D.Investor Relations914.345.7799michael.aberman@regeneron.comPeter DworkinCorporate Communications914.345.7800peter.dworkin@regeneron.com
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Post Your Comments:

(Date:5/19/2013)... , May 20, 2013 Whole-cell pertussis vaccines ... pertussis vaccines during a large recent outbreak, according to ... Whole-cell pertussis vaccines, also called DTwP, were available ... safety concerns that ultimately led to the development of ... the late 1990s, the United States ...

(Date:5/18/2013)... 2013 Although colonoscopy exams prevent many colon ... sensitive method for detecting colorectal cancers 2 , the ... 3 . EndoChoice ® Inc. today unveiled research ... the accuracy of this procedure and greatly reduces the ... discussing these clinical trial results and featuring the Fuse ...

(Date:5/18/2013)... 2013 Faruqi & Faruqi, LLP, a ... securities fraud at AVEO Pharmaceuticals, Inc. ("AVEO" or ... http://photos.prnewswire.com/prnh/20120119/MM38856LOGO ) The investigation focuses ... federal securities laws by issuing materially false and/or ... trials for Tivopath (tivozanib) (titled "TIVO-1"). Specifically, the ...

Breaking Medicine Technology:Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 2 Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 3 Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 4 New Study Shows Full Spectrum Endoscopy Procedure Reduces The 'Miss Rate' of Adenomas During Colonoscopy 2 New Study Shows Full Spectrum Endoscopy Procedure Reduces The 'Miss Rate' of Adenomas During Colonoscopy 3 Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm 2

[0] Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak [0] New Study Shows Full Spectrum Endoscopy Procedure Reduces The 'Miss Rate' of Adenomas During Colonoscopy [0] Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm

... 12, 2011 The board of directors of Eli Lilly ... dividend for the first quarter of 2012 of $0.49 a ... is payable March 9, 2012 to shareholders of record at ... Lilly, a leading innovation-driven corporation, is developing a growing portfolio ...

... (NASDAQ: AVNR ) today reported financial results for ... Quarterly Financial Highlights , Gross revenue for ... million Cash, cash equivalents, and restricted investments of $81.8 million ... "I am pleased with the foundation for commercial success that ...

Lilly Declares First-Quarter 2012 Dividend Avanir Pharmaceuticals Reports Fiscal 2011 Fourth Quarter and Year End Financial Results

(Date:5/20/2013)... predict when a particular strain of avian influenza might ... report to be published in the International Journal ... the University of Arizona, Tucson, and colleagues at the ... Wuhan Institute of Virology, explain that since 1997 several ... as "bird flu" have infected people directly from their ...

(Date:5/20/2013)... 2013 Soliant Health, a leading specialty healthcare ... voting for its fifth annual Most Beautiful Hospitals in the ... year, Soliant decided to bypass its routine selection process and ... received to be in the running for the 2013 Most ... May 20 and runs through June 23. Winners will be ...

(Date:5/20/2013)... 2013 Dr. Fanny J Berg, located in ... fractional laser treatment clinically proven to fight the effects aging ... Brilliant are designed to prevent and address signs of ... visibly illuminate skin tone, renew and smoothen skin texture, return ... the appearance of pores. Developed by the manufactures of ...

(Date:5/20/2013)... got bunions, chances are others in your family suffer ... finding the condition is often passed down from parents ... Arthritis Care & Research , researchers found that ... bunions or other toe deformities. "Our study is ... disorders in older adults," Dr. Marian Hannan, from Hebrew ...

(Date:5/20/2013)... Main Virtual Office , the ... several Mathnasium franchisee's to provide live answering services during ... we answer and transfer their calls according to their ... at a fraction of what they were being charged ... Virtual Office. "Core competency is critical" says Bernard ...

[0] Predicting infectious influenza [0] Vote for Soliant Health's 2013 Most Beautiful Hospitals in the U.S.[0] Delaware Dermatologist Now Offers Clear + Brilliant Gentle Laser Skin Rejuvenation Treatments [0] Many Can Blame Family for Their Bunions [0] Virtual Assistant and Mobile App Company - Main Virtual Office - Signs Up Several New Mathnasium Tutoring Centers

... Now Available on Online Community to Facilitate Collaboration ... BEACH, Fla., May 8 With a growing ... short weeks since launch, e-Zassi.com has added an ... participants involved in the discovery, development and commercialization ...

... York City Raises Money for STAR (TM) ... Charcot-Marie-Tooth Association,s second annual "Honor a Star. Be a Star." ... achievement raised a record amount of over $350,000 at the ... Proceeds earned from event sponsorship, ticket sales and auction items ...

... One Global Health Threat"WASHINGTON, May 8 Today, HIV ... of Human Virology at the University of Maryland ... of the World Foundation for AIDS Research and Prevention, ... six objectives to end the HIV/AIDS pandemic. They ...

... -- Mindray Medical,International Limited (NYSE: MR ... devices worldwide announced today it filed with the,Securities ... 20-F that included,audited financial statements for the year ... Annual Report on Form 20-F is available online,at ...

... part of the Elekta Group, has been selected to ... the 2009 American Society of Clinical Oncology,s (ASCO) Annual ... County Convention Center, in Orlando, Florida. Chosen according to ... third consecutive year Impac Software ...

... May 8, 2009 AMERIGROUP Corporation (NYSE: ... the Deutsche Bank 34th Annual Healthcare Conference on May 18 ... Monday, May 18 at 2:25pm Eastern Time, can be accessed ... the investors, page. A replay will be available for 30 ...

Cached Medicine News:Health News:New Advanced Search and Matching Function Drives e-Zassi.com's Enhanced Functionality 2 Health News:Charcot-Marie-Tooth Association's 'Honor a Star. Be a Star.' Gala Generates Over $350,000 for CMT Research 2 Health News:A Global Call to Action From HIV Co-Discoverers Robert Gallo and Luc Montagnier 2 Health News:A Global Call to Action From HIV Co-Discoverers Robert Gallo and Luc Montagnier 3 Health News:Mindray Files Annual Report on Form 20-F with U.S. Securities and Exchange Commission 2 Health News:Impac Software Selected to Present at the Electronic Health Records Lab During 2009 ASCO Annual Meeting 2

New Advanced Search and Matching Function Drives e-Zassi.com's Enhanced Functionality Charcot-Marie-Tooth Association's 'Honor a Star. Be a Star.' Gala Generates Over $350,000 for CMT Research A Global Call to Action From HIV Co-Discoverers Robert Gallo and Luc Montagnier Mindray Files Annual Report on Form 20-F with U.S. Securities and Exchange Commission Impac Software Selected to Present at the Electronic Health Records Lab During 2009 ASCO Annual Meeting AMERIGROUP Corporation to Present at The Deutsche Bank 34th Annual Healthcare Conference on May 18

... This is the comprehensive, simple and ... has a compact, bench-top design, but ... previously only found in high-volume systems. ... cost-effective solution and can also be ...

A complete workstation for haemostasis , A compact and convenient analyser , A comprehensive system , An exellent reliability: the STAGO patented detection mode...

... is a fully automated open random ... and immunological, latex based coagulation tests. ... 5-position racks as sample carrier offers ... up to 70 reagents on-board with ...

... Our high-quality MPD Lancets are designed with ... the tri-bevel, thin gauge needle with its ... smoother, less painful penetration without tearing the ... body is easy to grip, even for ...

Medicine Products:

Coag-A-Mate MTX II ST art Roche/STAGO STA-R Evolution®MPD Lancets